medline.ch Psychiatrie Schizophrenie und Psychosen

	Schizophrenia and accelerated ageing: systematic review and future research directions. Br J Psychiatry Fernandez-Egea E, Garcia-Rizo C, Kirkpatrick B. PMID: 42015596 [PubMed - as supplied by publisher]
	Psychosocial Factors Affecting Community Integration in Schizophrenia Patients: The Moderating Role of Perceived Policy Effectiveness. Brain Behav Co, Yalç. PMID: 42015585 [PubMed - indexed for MEDLINE]
	Methylphenidate and Psychotic Symptoms in Children and Adolescents: A Disproportionality Analysis on the WHO Safety Database (VigiBase). J Child Adolesc Psychopharmacol Chrétien B, Blouet C, Alexandre J, Jardri R, Nishida K, Desaunay P, Guénolé F. PMID: 42015492 [PubMed - indexed for MEDLINE]
	Antipsychotic dose is not associated with cognitive function in patients with schizophrenia aged under 40: a cross-sectional observational study with retrospective dose estimation. BMC Psychiatry Özkalayc, Ta, Küçük E, Uysal F. PMID: 42015170 [PubMed - as supplied by publisher]
	Driver or passenger? A new assessment of genes in the schizophrenia-associated 3q29 deletion locus for contribution to neurodevelopmental disorders. J Neurodev Disord Herriges AR, Purcell RH. PMID: 42015005 [PubMed - as supplied by publisher]
	Multimodal microglial and kynurenine pathway alterations across the affective-psychosis spectrum: a systematic review of patterns, heterogeneity, and dimensional implications. Mol Psychiatry Nussbaumer M, Guest PC, Schiltz K, Dudeck L, Asl LS, Meyer-Lotz G, Dobrowolny H, Leucht S, Bernstein HG, Nickl-Jockschat T, Fernandes BS, Steiner J. PMID: 42014469 [PubMed - as supplied by publisher]
	Corrigendum to "Effect of computerized cognitive remediation therapy combined with individualized occupational therapy on cognitive function and functional outcomes in patients with schizophrenia: A randomized controlled trial" [Psychiatry Research 354 (2025) 116789]. Psychiatry Res Hu G, Wei D, Zhang J, Liu J, Liao L, Zheng L, Wu H, Wu X, Wei B, Wan J. PMID: 42014217 [PubMed - as supplied by publisher]
	MicroRNAs as potential biomarkers in schizophrenia: Current methodological limitations and challenges. Prog Neuropsychopharmacol Biol Psychiatry Hernaez M, Parellada E, Brunet M. PMID: 42013994 [PubMed - as supplied by publisher]
	From brain bioenergetics to hypothalamic glucoregulation: A shared-systems hypothesis for intrinsic dysglycemia in schizophrenia. Rev Endocr Metab Disord Hamel L, Pereira S, Yang Z, Garrido AN, Agarwal SM, Lam TKT, Hahn MK. PMID: 42012619 [PubMed - as supplied by publisher]
	Quality of Life in early-phase schizophrenia patients starting treatment with long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST). Eur Psychiatry Schulze AT, Tschiderer L, Post F, Frajo-Apor B, Fleischhacker W, Davidson M, Hofer A. PMID: 42011073 [PubMed - as supplied by publisher]
	A Multidisciplinary Child-Adult Psychiatry Model to Refine the Risk of Psychotic Transition in Clinical High Risk Adolescents: A Clinical Case Study. Clin Child Psychol Psychiatry Sibut R, Rhetore L, Besse J, Lachal J. PMID: 42011015 [PubMed - as supplied by publisher]
	Mental health help-seeking by US college students with a diagnosis of psychosis. Soc Psychiatry Psychiatr Epidemiol Godoy-Henderson C, Denner SS, Flesaker M, Weinberg J, Dalhoe M, Lipson SK. PMID: 42010171 [PubMed - as supplied by publisher]
	Causal effects of gut microbiota on schizophrenia: deciphering profiles mediated by cerebrospinal fluid metabolites in the gut-brain axis. World J Biol Psychiatry Yang Y, Li T, Jing W, Qin W, Yang Q. PMID: 42008635 [PubMed - as supplied by publisher]
	Opportunities for Digital Health to Support Early Psychosis Care in Ghana: Qualitative Study Among Patients, Caregivers, and Clinicians. JMIR Form Res Larsen A, Agorinya J, Beaulieu A, Attah DA, Tauscher J, Asafo S, Buck B, Sottie EQ, DeVries E, Okyere AF, Ampaw M, Duah CA, Ofori-Atta A, Obeng K, Ben-Zeev D. PMID: 42008545 [PubMed - indexed for MEDLINE]
	Impact of abnormal metabolic-immunoinflammatory pathway on splenomegaly in patients with chronic schizophrenia and exploration of risk factors: case-control study. Front Psychiatry Shen Y, Wang D, Li Z. PMID: 42006049 [PubMed]
	Validation of the cognitive fusion questionnaire in regular meditators and persons with schizophrenia spectrum disorders. Front Psychol Bergmann N, Conell I, Hahne I, Zierhut M, Ta TMT, Hahn E, Böge K. PMID: 42005019 [PubMed]
	Jumping to conclusions and social behavior in individuals diagnosed with schizophrenia. Schizophr Res Cogn Hayashi R, Takahama Y, Inadomi H, Ishii R, Watanabe S, Yoshida K, Okada H, Yoshimura M. PMID: 42004482 [PubMed]
	Developmental trajectories of social responsiveness and theory of mind in adolescent offspring at familial high-risk of schizophrenia or bipolar disorder and population-based controls-The Danish High Risk and Resilience Study, VIA 15. Br J Clin Psychol Veddum L, Laursen AF, Bundgaard AF, Hemager N, Gregersen M, Krantz MF, Vaskinn A, Jepsen JRM, Søndergaard A, Rohd SB, Wilms M, Schiavon M, Streymá DHB, Thorup AAE, Nordentoft M, Mors O, Greve AN. PMID: 42003073 [PubMed - as supplied by publisher]
	Metabolic syndrome in chronic schizophrenia: Cross-sectional hospital assessment of prolonged risperidone exposure. Pak J Pharm Sci Wu Y, Wu J, Deng Z, Xiao T. PMID: 42001294 [PubMed - indexed for MEDLINE]
	Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling. Transl Psychiatry Arjmand S, Chaudhary M, Samudyata, Piehl F, Pelanis A, Engberg G, Cervenka S, Landén M, Erhardt S, Sellgren CM. PMID: 42000733 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 68607

Seite 1 von 3431



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung